CRSP CRISPR Therapeutics
- 45.710
- +0.130+0.29%
- 45.800
- +0.090+0.20%
CRISPR Therapeutics News
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
CRISPR Therapeutics | 424B5: Prospectus
Analysis
Price Target
No Data
No Data
